Literature DB >> 9422803

Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability.

H L Willingale1, N J Gardiner, N McLymont, S Giblett, B D Grubb.   

Abstract

1. The responses of wide dynamic range spinal dorsal horn neurones to noxious mechanical stimulation of the ankle or knee joint were tested before and after spinal administration of the non-selective cyclooxygenase (COX) inhibitors, indomethacin and meclofenamic acid. Neither of these drugs altered the responses of these neurones to noxious mechanical stimulation. 2. Wind-up of a spinal nociceptive reflex evoked by electrical stimulation of the sural nerve at C-fibre strength was dose-dependently inhibited by intravenous administration of indomethacin, a non-selective COX inhibitor, and SC58125, a selective COX-2 inhibitor. Intrathecal administration of indomethacin also reduced the wind-up of this nociceptive reflex. 3. Western blot analysis of proteins extracted from normal rat spinal cord revealed the presence of both cyclo-oxygenase (COX)-1 and COX-2 proteins. 4. Immunocytochemistry of sections of normal rat spinal cord with specific COX-1 antiserum revealed little specific COX-1-like immunoreactivity in the grey matter. With the same antiserum, intense COX-1-like immunoreactivity was observed in the cytoplasm, nuclear membrane and axonal processes of small to medium sized (< 1000 microns2) dorsal root ganglion (DRG) cell bodies. 5. Immunocytochemistry of sections of normal rat spinal cord incubated with specific COX-2 antiserum showed intense COX-2-like immunoreactivity (COX-2-li) in the superficial dorsal horn of the spinal cord (laminae I and II) and around the central canal (lamina X). COX-2-li was also observed in some neurones in deep dorsal horn and in individual motor neurones in ventral horn. COX-2-li was not observed in the cell bodies of DRG. 6. Superfusion of the lumbar spinal cord of normal rats with artificial CSF and subsequent radioimmunoassay revealed the presence of prostaglandin D2 (PGD2) < PGE2, but not PGI2 (determined by measurement of the stable metabolite, 6-keto-PGF1 alpha) or PGF2 alpha. 7. These data suggest that eicosanoids synthesized by an active COX pathway in the spinal cord of normal animals may contribute to nociceptive processing, but only when the spinal cord neurones are rendered hyperexcitable following C-fibre stimulation. Selective inhibition of one or both of the COX isoforms in normal animals may represent a novel target for spinal analgesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422803      PMCID: PMC1565107          DOI: 10.1038/sj.bjp.0701548

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

Review 1.  Transcriptional and epigenetic regulation of Hebbian and non-Hebbian plasticity.

Authors:  Mikael C Guzman-Karlsson; Jarrod P Meadows; Cristin F Gavin; John J Hablitz; J David Sweatt
Journal:  Neuropharmacology       Date:  2014-01-10       Impact factor: 5.250

2.  In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin.

Authors:  D M Dirig; T L Yaksh
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 3.  Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy.

Authors:  J A Mitchell; T D Warner
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Cyclooxygenase-2 inhibitor inhibits hippocampal synaptic reorganization in pilocarpine-induced status epilepticus rats.

Authors:  Hai-Ju Zhang; Ruo-Peng Sun; Ge-Fei Lei; Lu Yang; Chun-Xi Liu
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

5.  Sex differences in basal and cocaine-induced alterations in PKA and CREB proteins in the nucleus accumbens.

Authors:  Arbi Nazarian; Wei-Lun Sun; Luyi Zhou; Lynne M Kemen; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

6.  Role of prostaglandin D2 in mast cell activation-induced sensitization of esophageal vagal afferents.

Authors:  Shizhong Zhang; Gintautas Grabauskas; Xiaoyin Wu; Moon Kyung Joo; Andrea Heldsinger; Il Song; Chung Owyang; Shaoyong Yu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-07       Impact factor: 4.052

7.  Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans.

Authors:  Frédéric Martin; Dominique Fletcher; Marcel Chauvin; Didier Bouhassira
Journal:  Anesthesiology       Date:  2007-05       Impact factor: 7.892

8.  A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee.

Authors:  M Bianchi; M Broggini
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  The role of COX-2 inhibitors in pain modulation.

Authors:  Frederic Camu; Lin Shi; Caroline Vanlersberghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.

Authors:  Gema Gaitan; F Javier Ahuir; Piero Del Soldato; Juan F Herrero
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.